iifl-logo-icon 1

Solara Active Pharma Sciences Ltd Share Price

672
(-0.72%)
Jan 17, 2025|03:29:54 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open676.9
  • Day's High683.5
  • 52 Wk High882.8
  • Prev. Close676.9
  • Day's Low666
  • 52 Wk Low 322.53
  • Turnover (lac)215.59
  • P/E0
  • Face Value10
  • Book Value258.82
  • EPS0
  • Mkt. Cap (Cr.)2,422.85
  • Div. Yield0
View All Historical Data
No Records Found

Solara Active Pharma Sciences Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

676.9

Prev. Close

676.9

Turnover(Lac.)

215.59

Day's High

683.5

Day's Low

666

52 Week's High

882.8

52 Week's Low

322.53

Book Value

258.82

Face Value

10

Mkt Cap (₹ Cr.)

2,422.85

P/E

0

EPS

0

Divi. Yield

0

Solara Active Pharma Sciences Ltd Corporate Action

14 Oct 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

28 Aug 2024

12:00 AM

BookCloser

arrow

29 Aug 2024

12:00 AM

AGM

Announcement Date: 29 Aug, 2024

arrow

9 May 2024

12:00 AM

Rights

arrow

Solara Active Pharma Sciences Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Solara Active Pharma Sciences Ltd SHAREHOLDING SNAPSHOT

18 Jan, 2025|07:20 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 37.26%

Foreign: 0.00%

Indian: 37.26%

Non-Promoter- 17.63%

Institutions: 17.63%

Non-Institutions: 45.10%

Custodian: 0.00%

Share Price

Solara Active Pharma Sciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

36

36

36

35.93

Preference Capital

0

0

0

0

Reserves

901.42

1,467.13

1,491.05

1,556.86

Net Worth

937.42

1,503.13

1,527.05

1,592.79

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

1,268.34

1,616.88

1,321.75

560.4

yoy growth (%)

-21.55

22.32

135.85

Raw materials

-653.89

-724.41

-598.87

-293.32

As % of sales

51.55

44.8

45.3

52.34

Employee costs

-234.2

-227.63

-202.24

-69.51

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

-88.17

220.96

112.49

1.95

Depreciation

-112.01

-108.31

-93.67

-36.55

Tax paid

33.1

0

0

0

Working capital

200.65

302.71

157.99

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-21.55

22.32

135.85

Op profit growth

-79.14

50.2

317.87

EBIT growth

-104.22

60.44

601.98

Net profit growth

-126.5

96.42

5,668.71

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

1,288.92

1,443.81

1,268.34

1,616.88

1,321.75

Excise Duty

0

0

0

0

0

Net Sales

1,288.92

1,443.81

1,268.34

1,616.88

1,321.75

Other Operating Income

0

0

0

0

0

Other Income

5.37

22.55

20.02

28.77

27.52

Solara Active Pharma Sciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,786.55

153.484,23,122.72863.290.775,123.6798.33

Divis Laboratories Ltd

DIVISLAB

5,916.05

85.561,57,170.675180.512,302513.62

Cipla Ltd

CIPLA

1,442.3

27.541,16,579.091,178.160.93,969.86360.73

Dr Reddys Laboratories Ltd

DRREDDY

1,309.4

22.611,08,750.471,882.10.616,678.8322.47

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,174.85

65.781,07,610.664600.882,376222.38

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Solara Active Pharma Sciences Ltd

Management

Register Office

Registrar Office

Chairman & Independent Directo

RAJAGOPALAN RAMAKRISHNAN

Independent Director

Kausalya Santhanam

Non Executive Director

Arun Kumar

Managing Director & CEO

Poorvank Purohit

Independent Director

Rajendra Kumar Srivastava

Non Executive Director

Rajiv Vijay Nabar

Non Executive Director

Kartheek Chintalapati Raju

Non Executive Director

Manish Gupta

Executive Director & COO

M Mohan

Company Sec. & Compli. Officer

S Murali Krishna

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Reports by Solara Active Pharma Sciences Ltd

Summary

Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs). The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets. The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others. It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches. Apart from this, the Solara Active has two research and development units - in Bengaluru and Chennai - equipped with state-of-the-art facilities and a pipeline of 25+ products, at different stages of development. These drugs primarily deal with anthelmintic, anti-malarias, beta blockers, muscle relaxants, novel oral anticoagulants, anti-infective and other niche segments.The Companys manufacturing facilities enjoy regulatory approvals from the United States Food and Drug Administration (USFDA); European Directorate for the Quality of Medicines (EDQM); Korea Food & Drug Administration (KFDA) - South Korea; Euro Zone - Good Ma
Read More

Company FAQs

What is the Solara Active Pharma Sciences Ltd share price today?

The Solara Active Pharma Sciences Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹672 today.

What is the Market Cap of Solara Active Pharma Sciences Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Solara Active Pharma Sciences Ltd is ₹2422.85 Cr. as of 17 Jan ‘25

What is the PE and PB ratio of Solara Active Pharma Sciences Ltd?

The PE and PB ratios of Solara Active Pharma Sciences Ltd is 0 and 2.25 as of 17 Jan ‘25

What is the 52 Week High and Low of Solara Active Pharma Sciences Ltd?

The 52-week high/low is the highest and lowest price at which a Solara Active Pharma Sciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Solara Active Pharma Sciences Ltd is ₹322.53 and ₹882.8 as of 17 Jan ‘25

What is the CAGR of Solara Active Pharma Sciences Ltd?

Solara Active Pharma Sciences Ltd's CAGR for 5 Years at 10.75%, 3 Years at -12.64%, 1 Year at 70.41%, 6 Month at 19.75%, 3 Month at -13.94% and 1 Month at -6.36%.

What is the shareholding pattern of Solara Active Pharma Sciences Ltd?

The shareholding pattern of Solara Active Pharma Sciences Ltd is as follows:
Promoters - 37.27 %
Institutions - 17.63 %
Public - 45.10 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.